poisar

Stock

Bio-Techne Corp TECH

$72.17+0.19%

Overview

TECH market data

Price History

TECH price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
103.97
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.46
Diluted earnings per share over the trailing twelve months.
Beta
1.28
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
44.4%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$43.20 – $72.37
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $11.3K · P/B 4.20 · P/S 9.31.

Company News

10 captured
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible TakeoverBenzinga · Jul 10, 2026, 1:30 PM
RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73Benzinga · Jul 9, 2026, 3:25 PM
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their ShareholdersGlobenewswire Inc · Jul 6, 2026, 6:15 PM
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73Benzinga · Jun 30, 2026, 1:40 PM
Benchmark Downgrades Bio-Techne to HoldBenzinga · Jun 30, 2026, 1:20 PM
Citigroup Downgrades Bio-Techne to Neutral, Raises Price Target to $73Benzinga · Jun 29, 2026, 1:15 PM
Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73Benzinga · Jun 26, 2026, 3:30 PM
William Blair Downgrades Bio-Techne to Market PerformBenzinga · Jun 26, 2026, 2:55 PM
Baird Maintains Neutral on Bio-Techne, Raises Price Target to $73Benzinga · Jun 26, 2026, 11:25 AM
8-K filing — BIO-TECHNE Corp (TECH)SEC EDGAR · Jun 25, 2026, 10:49 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock